NIH Gifts Super Bacteria Tech for Custom Immune Cells
Published Date: 7/2/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is planning to give CZ Biohub SF, LLC exclusive rights to special technology that helps create immune cells using engineered friendly bacteria. This deal affects researchers and could speed up new treatments for diseases. The agreement will bring focused innovation and may involve funding changes soon.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
NIH Plans Exclusive License to CZ Biohub
The National Institute of Allergy and Infectious Diseases (NIAID) plans to grant CZ Biohub SF, LLC in San Francisco an exclusive inter‑institutional agreement for listed technologies and patent applications that help generate antigen‑specific T and B cells using engineered commensal bacteria. The notice says this deal affects researchers and could speed up new treatments for diseases.
Agreement May Involve Funding Changes Soon
The notice states the inter‑institutional agreement with CZ Biohub SF, LLC may involve funding changes soon. That could affect researchers or institutions tied to this technology.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06501 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health is offering a cool new invention—special human antibodies that can fight certain cancers and autoimmune diseases—for companies to license and develop into treatments. This means businesses can jump on this opportunity to create powerful new medicines using government-backed research. Interested parties should act soon and may need to sign agreements to get full details.
2026-06283 — Prospective Grant of an Exclusive Patent License: Pigment Epithelium-Derived Factor (PEDF) Peptides and Use for Treating Retinal Degeneration
The National Eye Institute plans to give Perpetual Biosciences, Inc. an exclusive license to use special PEDF peptides to treat eye diseases that cause vision loss. This means the company will have the sole right to develop and sell this promising treatment, potentially helping millions with retinal degeneration. If you want to comment or apply for a license, act fast—submissions close April 16, 2026!
2026-05957 — Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding several closed virtual meetings in April 2026 to review and decide on important research grant applications. These meetings affect scientists seeking funding in areas like neuroscience, cancer, and liver disease. No public access is allowed to protect private info and trade secrets, and these reviews help decide where millions in research money will go.
2026-05672 — National Institute on Deafness and Other Communication Disorders; Notice of Closed Meetings
The National Institute on Deafness and Other Communication Disorders is holding two closed meetings in late April and early May 2026 to review grant applications and evaluate researchers’ qualifications. These meetings affect scientists seeking funding and help ensure top-notch research gets supported. No public access means privacy is protected, and the process keeps the money flowing to the best projects on time.
2026-05673 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings on April 17, 2026, to review and evaluate important grant applications in health and science fields. These meetings protect private info and trade secrets while deciding who gets funding. Researchers and organizations applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-05738 — Submission for OMB Review; 30-Day Comment Request; National Institutes of Health (NIH) Loan Repayment Programs, (Office of the Director)
The NIH is asking for a 30-day public comment on extending its Loan Repayment Programs that help doctors and scientists pay off their student loans while they do important health research. This extension keeps the program running smoothly with no big changes, and comments are due by April 23, 2026. If you’re a researcher with student loans, this program could save you money while you help improve health!
Previous / Next Documents
Previous: 2025-12380 — Administrative Declaration of an Economic Injury Disaster for the State of California
California businesses in Los Angeles County hit by civil unrest can now apply for special disaster loans to help bounce back. These loans offer extra money and time to recover from the damage caused. Act fast—applications opened June 27, 2025, so don’t miss your chance to get financial support!
Next: 2025-12382 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early August 2025 to review important grant applications related to brain research, immunology, and neurodevelopment. These meetings protect private info and trade secrets while deciding which projects get funding. Scientists applying for grants and the research community should watch these dates closely as they impact future research funding.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in